The global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period. This growth is ...
About two million American men undergo transrectal biopsies each year to diagnose prostate cancer or to monitor low-risk and favorable intermediate-risk prostate cancers for active surveillance (AS).
If the Crossfire debate at the American Urological Association (AUA) virtual annual meeting is any indication, advocates for transperineal (TP) biopsies face an uphill battle in persuading U.S.
Extended analysis of a validated urine-exosome signature to predict high grade prostate cancer on initial biopsy: Performance across multiple sub-groups. This is an ASCO Meeting Abstract from the 2016 ...
Prostate Biopsy Findings. PROSTATE biopsy under local anesthesia showed similar safety and detection outcomes, with better ...
Associations between patient sociodemographic factors and non-treatment for localized prostate cancer. N represents the total number of biopsies in each variable category. The mean difference is the ...
Transperineal prostate biopsy shows comparable detection with fewer infections than transrectal biopsy. Learn more about this real-world study.
April 29, 2003 (Chicago) — Transrectal high-intensity focused ultrasound (HIFU) therapy appears to be safe and effective for treating benign prostatic hyperplasia (BPH), according to a new study ...
When it comes to prostate biopsy, is the transperineal or transrectal route better? Urologists are currently awaiting results from ongoing clinical trials exploring whether transperineal prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results